Atricure Inc. Stock
Price
Target price
-
-
-
-
-
?44.64
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Atricure Inc. Stock
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Atricure Inc..
However, we have a potential of -26.05% for Atricure Inc. as the target price of 44 € is below the current price of 59.5 €.
Pros and Cons of Atricure Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atricure Inc. | - | - | - | - | - | - | - |
| Orasure Tech | -0.980% | 4.508% | -11.304% | -18.400% | -31.544% | -36.928% | -40.028% |
| scPharmaceuticals | -7.800% | 9.000% | -7.627% | -51.556% | -24.174% | -20.727% | - |
| SI-BONE Inc | -2.140% | -0.709% | -0.709% | -26.702% | -26.316% | -51.049% | - |
Comments
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $57.00 to $58.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
